In Europe, 2024 marks the year when exclusivity for a diverse range of drugs encompassing various therapeutic categories is set to expire. This includes established medications like Cabometyx and Zavicefta
Streaming crystal-clear 8K content on a phone without buffering, even on unreliable internet, is no longer a far-fetched thought. This seemingly magical experience relies heavily on the intricate video compression
In the eight months since its introduction, the Unitary Patent System has initiated a significant transformation in the field of patent law within the European Union. This article aims to
Even as customers’ demand for dairy-free products grows, sales of most plant-based products have sharply declined over the past year. One of the primary reasons consumers reject plant-based foods is
The arthritis treatment industry is characterized by its intense competitiveness, driving companies to invest significantly in research and development to secure leading arthritis drug patents. Consequently, the expiration of patents
Acquiring multiple patents over time will result in a portfolio that may or may not align with a company’s objectives, values, and goals. Therefore, to ensure a stronger, more relevant
The standard approach to prove product overlap during patent infringement analysis involves researching online resources such as product manuals, datasheets, and FAQs. However, online literature won’t always provide conclusive evidence
AI (Artificial Intelligence) has transformed intellectual property (IP) by reducing human effort and enabling patent experts to refine how they discover, analyze, and leverage intellectual property. It’s no surprise that
Exploring additional revenue streams beyond the primary product line is a common goal for many companies. However, the monetization department often encounters numerous obstacles when venturing into licensing patents. Initially,
It is not uncommon for companies to engage in aggressive patent pruning due to budgetary constraints. However, what if one could analyze the licensing potential of these patents before the
More than 500 million people around the world are affected by diabetes, and this issue is intensified by a surging obesity crisis, particularly in wealthier nations. In such a crisis,
The fiercely competitive nature of the oncology industry makes the companies invest heavily in research and development to bring in top cancer-treating drug patents. Consequently, the expiration of patents for
When Nick, a legal counsel representing a major Non-Practicing Entity (NPE) in the United States, approached us, his goal was to acquire 200 patents from a portfolio of 1000 within
Given the competitive nature of the pharmaceutical domain, the expiration of drug patents presents significant opportunities, particularly for companies specializing in generic medications. Pharmaceutical companies seeking to expand or diversify
A patent family is an unparalleled fortress, strategically safeguarding intellectual property across multiple jurisdictions. It forms a robust defense, enabling swift and global protection against unauthorized use of innovative concepts.